Evidence map›Paper›PMID 37823016›Full record

ArticleInternational journal of particle therapy2023

Cognition and Brain System Segregation in Pediatric Brain Tumor Patients Treated with Proton Therapy.

Anna V Dowling, Benjamin A Seitzman, Timothy J Mitchell, Michael Olufawo, Donna L Dierker, Hari Anandarajah, Ally Dworetsky, Alana McMichael, Catherine Jiang, Dennis L Barbour and 6 more

Open access · diamondAbstract read
In one paragraph

Article in International journal of particle therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Anna V DowlingDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Benjamin A SeitzmanDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Timothy J MitchellDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Michael OlufawoDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Donna L DierkerMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Hari AnandarajahDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Ally DworetskyMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Alana McMichaelDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, USA.
Catherine JiangDepartment of Biomedical Engineering, Washington University School of Medicine, St. Louis, MO, USA.
Dennis L BarbourDepartment of Biomedical Engineering, Washington University School of Medicine, St. Louis, MO, USA.
Bradley L SchlaggarKennedy Krieger Institute, Baltimore, MD, USA.
David D LimbrickDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Jennifer M StrahleDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Joshua B RubinDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Joshua S ShimonyMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
Stephanie M PerkinsDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Washington University in St. Louis · USMallinckrodt (United States) · USNeurological Surgery · USKennedy Krieger Institute · US

Funding

WUIDDRC Supplement-Supporting the health and well-being of children with intellectual and developmental disability during COVID-19 pandemicP50HD103525 · NICHD · WASHINGTON UNIVERSITY · PI JOSEPH D DOUGHERTY, Natasha Marrus · 2020 to 2026
$15.5M
Sleep and Circadian Dysfunction, Brain and Neurobehavioral Development in AutismP50HD103538 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI S. Ali Fatemi, Bradley L Schlaggar · 2020 to 2026
$9.9M
NICHD NIH HHS P50 HD103525NICHD NIH HHS P50 HD103538
6 · The paper itself

Abstract

Purpose: Pediatric brain tumor patients often experience significant cognitive sequelae. Resting-state functional MRI (rsfMRI) provides a measure of brain network organization, and we hypothesize that pediatric brain tumor patients treated with proton therapy will demonstrate abnormal brain network architecture related to cognitive outcome and radiation dosimetry. Participants and Methods: Pediatric brain tumor patients treated with proton therapy were enrolled on a prospective study of cognitive assessment using the NIH Toolbox Cognitive Domain. rsfMRI was obtained in participants able to complete unsedated MRI. Brain system segregation (BSS), a measure of brain network architecture, was calculated for the whole brain, the high-level cognition association systems, and the sensory-motor systems. Results: Twenty-six participants were enrolled in the study for cognitive assessment, and 18 completed rsfMRI. There were baseline cognitive deficits in attention and inhibition and processing speed prior to radiation with worsening performance over time in multiple domains. Average BSS across the whole brain was significantly decreased in participants compared with healthy controls (1.089 and 1.101, respectively; Conclusion: Higher mean dose to the right hippocampus correlated with worse dorsal attention network segregation and worse attention and inhibition cognitive performance. Patients demonstrated alterations in brain network organization of association systems measured with rsfMRI; however, somatosensory system segregation was no different from healthy children. Further work with preradiation rsfMRI is needed to assess the effects of surgery and presence of a tumor on brain network architecture.

Indexed as

brain tumorlate effectsneurocognitiveproton therapyresting state

Identifiers

PMID37823016
PMCPMC10563667
OpenAlexW4385208996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.